FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012168857> ?p ?o ?g. }

• W2012168857 endingPage "659" @default.
• W2012168857 startingPage "650" @default.
• W2012168857 abstract "Diabetes mellitus is a serious debilitating epidemic affecting all social strata in developing as well as developed countries. Diabetic neuropathy is most common of secondary complications associated with diabetes mellitus and is characterized by slowing of nerve conduction velocity, elevated pain, sensory loss and nerve fiber degeneration. The aim of the present investigation was to evaluate the neuroprotective effect of naringin against streptozotocin (STZ) induced diabetic neuropathic pain in laboratory rats. Four weeks after intraperitoneal injection of STZ resulted in significant decrease in mechano-tactile allodynia, mechanical hyperalgesia, thermal hyperalgesia and motor nerve conduction velocity. Activity of endogenous antioxidant like superoxide dismutase as well as membrane bound inorganic phosphate enzyme was also found to be significantly decreased. It not only caused neural cell apoptosis but also enhanced lipid peroxide, nitrite, and inflammatory mediators' (TNF-α) level. Chronic treatment with naringin (40 and 80mg/kg) for 4 weeks significantly and dose dependently attenuated the decrease in level of nociceptive threshold, endogenous antioxidant and membrane bound inorganic phosphate enzyme. It also decreased the elevated levels of oxidative-nitrosative stress, inflammatory mediators as well as apoptosis in neural cells significantly and dose dependently. The important finding of the study is that, the naringin-insulin combination not only attenuated the diabetic condition but also reversed the neuropathic pain, whereas insulin or naringin alone only improved hyperglycemia but partially reversed the pain response in diabetic rats. Thus, naringin is a potential flavonone bearing antioxidant, antiapoptotic and disease modifying property acting via modulation of endogenous biomarker to inhibit diabetes induced neuropathic pain." @default.
• W2012168857 created "2016-06-24" @default.
• W2012168857 creator A5000496283 @default.
• W2012168857 creator A5008189563 @default.
• W2012168857 creator A5077257636 @default.
• W2012168857 creator A5083288322 @default.
• W2012168857 creator A5083350984 @default.
• W2012168857 date "2012-06-01" @default.
• W2012168857 modified "2023-10-14" @default.
• W2012168857 title "Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy" @default.
• W2012168857 cites W1750690213 @default.
• W2012168857 cites W1797956204 @default.
• W2012168857 cites W1899938340 @default.
• W2012168857 cites W1964994058 @default.
• W2012168857 cites W1965026439 @default.
• W2012168857 cites W1972060131 @default.
• W2012168857 cites W1974560120 @default.
• W2012168857 cites W1977926706 @default.
• W2012168857 cites W1987517634 @default.
• W2012168857 cites W1990722453 @default.
• W2012168857 cites W1991774590 @default.
• W2012168857 cites W1993656308 @default.
• W2012168857 cites W1996424575 @default.
• W2012168857 cites W2000394413 @default.
• W2012168857 cites W2003762048 @default.
• W2012168857 cites W2006009427 @default.
• W2012168857 cites W2013145726 @default.
• W2012168857 cites W2013588043 @default.
• W2012168857 cites W2020267609 @default.
• W2012168857 cites W2023096054 @default.
• W2012168857 cites W2023126063 @default.
• W2012168857 cites W2024976171 @default.
• W2012168857 cites W2025958954 @default.
• W2012168857 cites W2026844811 @default.
• W2012168857 cites W2037699476 @default.
• W2012168857 cites W2045232429 @default.
• W2012168857 cites W2050629341 @default.
• W2012168857 cites W2054356349 @default.
• W2012168857 cites W2055935186 @default.
• W2012168857 cites W2065276108 @default.
• W2012168857 cites W2069675298 @default.
• W2012168857 cites W2069886558 @default.
• W2012168857 cites W2076897283 @default.
• W2012168857 cites W2087813618 @default.
• W2012168857 cites W2088208009 @default.
• W2012168857 cites W2091945543 @default.
• W2012168857 cites W2109430885 @default.
• W2012168857 cites W2112374588 @default.
• W2012168857 cites W2131840341 @default.
• W2012168857 cites W2155863194 @default.
• W2012168857 cites W2165503694 @default.
• W2012168857 cites W2172201406 @default.
• W2012168857 cites W2769264260 @default.
• W2012168857 cites W2921356930 @default.
• W2012168857 cites W4253134632 @default.
• W2012168857 doi "https://doi.org/10.1016/j.fitote.2012.01.010" @default.
• W2012168857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22343014" @default.
• W2012168857 hasPublicationYear "2012" @default.
• W2012168857 type Work @default.
• W2012168857 sameAs 2012168857 @default.
• W2012168857 citedByCount "185" @default.
• W2012168857 countsByYear W20121688572012 @default.
• W2012168857 countsByYear W20121688572013 @default.
• W2012168857 countsByYear W20121688572014 @default.
• W2012168857 countsByYear W20121688572015 @default.
• W2012168857 countsByYear W20121688572016 @default.
• W2012168857 countsByYear W20121688572017 @default.
• W2012168857 countsByYear W20121688572018 @default.
• W2012168857 countsByYear W20121688572019 @default.
• W2012168857 countsByYear W20121688572020 @default.
• W2012168857 countsByYear W20121688572021 @default.
• W2012168857 countsByYear W20121688572022 @default.
• W2012168857 countsByYear W20121688572023 @default.
• W2012168857 crossrefType "journal-article" @default.
• W2012168857 hasAuthorship W2012168857A5000496283 @default.
• W2012168857 hasAuthorship W2012168857A5008189563 @default.
• W2012168857 hasAuthorship W2012168857A5077257636 @default.
• W2012168857 hasAuthorship W2012168857A5083288322 @default.
• W2012168857 hasAuthorship W2012168857A5083350984 @default.
• W2012168857 hasConcept C126322002 @default.
• W2012168857 hasConcept C134018914 @default.
• W2012168857 hasConcept C15490471 @default.
• W2012168857 hasConcept C170493617 @default.
• W2012168857 hasConcept C179253579 @default.
• W2012168857 hasConcept C185592680 @default.
• W2012168857 hasConcept C25498285 @default.
• W2012168857 hasConcept C2775838275 @default.
• W2012168857 hasConcept C2776151105 @default.
• W2012168857 hasConcept C2777107010 @default.
• W2012168857 hasConcept C2777335409 @default.
• W2012168857 hasConcept C2777883359 @default.
• W2012168857 hasConcept C2779178840 @default.
• W2012168857 hasConcept C2779245659 @default.
• W2012168857 hasConcept C2779280383 @default.
• W2012168857 hasConcept C2993790521 @default.
• W2012168857 hasConcept C43617362 @default.
• W2012168857 hasConcept C555293320 @default.
• W2012168857 hasConcept C71924100 @default.

• next